Altesa BioSciences

Altesa BioSciences Reports Positive Phase 2 Vapendavir Data in COPD

ORLANDO, Fla., May 19, 2026 Altesa BioSciences announced positive results from its randomized, placebo-controlled Phase 2 rhinovirus challenge study...

By cGxPwire Editor
May 20, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

Altesa BioSciences

Altesa BioSciences Reports Positive Phase 2 Vapendavir Data in COPD